% | $
Quotes you view appear here for quick access.

Repligen Corporation Message Board

  • zero1sum zero1sum Mar 27, 2013 8:27 PM Flag

    Biogen's big score is our score too.

    WASHINGTON (Reuters) - U.S. regulators on Wednesday approved a new multiple sclerosis drug made by Biogen Idec Inc that is widely expected to become the No. 1 oral treatment for the disease, with annual sales topping $3 billion Tecfridera or BG-12 has a Monoclonal antibodies train I'm pretty sure. Have a nice holiday.

28.64-0.18(-0.62%)Oct 27 4:00 PMEDT